About Inscopix
Inscopix specializes in neuroscience by developing miniature microscopes for real-time brain mapping. Their main product, the "miniscope," enables researchers to perform calcium imaging and manipulate neural activity in brain circuits while observing behavior. This technology helps scientists understand how different brain regions communicate and function together. Inscopix differentiates itself from competitors by not only selling these advanced microscopes but also providing extensive support services, including intuitive data analysis software, training workshops, and consultations. Their goal is to facilitate groundbreaking discoveries in brain science by equipping researchers with the tools and knowledge they need to succeed.
Mountain View, CaliforniaHeadquarters
2011Year Founded
$9.7MTotal Funding
SERIES_ACompany Stage
Data & Analytics, Biotechnology, HealthcareIndustries
51-200Employees
Benefits
401k plan & stock options
No-cost health plan with low-cost family plans
Generous PTO
Health & wellness benefits
Risks
Bruker's acquisition may lead to strategic shifts affecting product offerings and relationships.
Customizable options like nVista Essential may increase competition from similar solutions.
Dependency on Noldus technology poses risks if the partnership faces disruptions.
Differentiation
Inscopix offers unique miniscope technology for real-time brain mapping in natural settings.
Their nVision System synchronizes behavioral movies with in vivo miniscope data seamlessly.
Inscopix's IDEAS Platform enhances data sharing and analysis for neuroscience research.
Upsides
The acquisition by Bruker could accelerate Inscopix's product development and market reach.
nVista Essential package attracts budget-conscious academic institutions, broadening market appeal.
Partnership with Noldus enhances product offerings, attracting behavioral neuroscience customers.
Funding
Total raised$9.73 M
Latest valuation$50.00 M
StageSERIES_A
SERIES A
7/31/2016$10
$50.00 M